In IFNγ-treated glioma cells, inhibiting RIG-I through siRNA mediated knockdown elevated ROS levels, but IFNγ itself had no effect on ROS production, which confirmed that RIG-I mediated the regulation for ROS generation [91]. The gene discussed is IFNG; the disease is central nervous system cancer.